Indeed the SequestOx halt and shelving - for however long - has been more than painful to long term investors - still, to pretend Elite hasn't moved forward with its generic pipeline to the advantage of the company misses what Nasrat has been working on for the past 2 years.
The .02's aren't coming bc of Elite's R&D work in that very last 2 year period.
There hasn't been a single post that has offered a single piece of validity to the .02 cent is coming BS.
Market Data 
Markets 
AI
